Private Equity Acquires UK Pharma Firm in £703.1m Deal: Ergomed Founder Receives £120m Windfall
Private equity has made another acquisition in the UK, with the founder of the company receiving a windfall of over £120 million.
Permira, a leading buyout firm, has agreed to purchase Ergomed, a pharmaceutical services group, for £703.1 million. This deal may result in Ergomed becoming the latest company to leave the London stock market.
The offer of 1350p per share caused the stock of Ergomed, which is listed on the AIM, to surge by 28.1%, reaching 1348p.
The founder and executive chairman of Ergomed, Miroslav Reljanovic, holds an 18% stake in the company, which is valued at £123 million.
Windfall: Ergomed founder Miroslav Reljanovic’s stake in the biotech firm is currently valued at £123m
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
